Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 2, 2011, Pages 320-329

  Sharma, Bhupesh ^a   Singh, Nirmal ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Alzheimer's disease; Donepezil; Morris water maze; Oxidative stress; Pioglitazone; Vascular endothelial dysfunction

Indexed keywords

ACETYLCHOLINESTERASE; DONEPEZIL; GLUCOSE; GLUTATHIONE; NITRATE; NITRITE; PIOGLITAZONE; ROSIGLITAZONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL FUNCTION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; LEARNING; MALE; MAZE TEST; MEMORY; MULTIINFARCT DEMENTIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASCULAR ENDOTHELIUM;

ANIMALS; BEHAVIOR, ANIMAL; DEMENTIA, VASCULAR; DIABETES MELLITUS, EXPERIMENTAL; MALE; OXIDATIVE STRESS; PPAR GAMMA; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 80054812684     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.08.020     Document Type: Article

References (85)

1. A. Araki Dementia and insulin resistance in patients with diabetes mellitus Nippon Rinsho 68 3 2010 569 574
2. P. Arck, B. Toth, A. Pestka, and U. Jeschke Nuclear receptors of the peroxisome proliferator-activated (PPAR) family in gestational diabetes - from animal models to clinical trials Biol Reprod 83 2010 168 176
3. V. Bermudez, F. Finol, N. Parra, M. Parra, A. Pérez, and L. Peñaranda PPAR-gamma agonists and their role in type 2 diabetes mellitus management Am J Ther 17 2010 274 283
4. E. Beutler, O. Duron, and B. Kelly Reduced glutathione estimation J Lab Clin Med 61 1963 82
5. A.M. Beyer, G.L. Baumbach, C.M. Halabi, M.L. Modrick, C.M. Lynch, and T.D. Gerhold Interference with PPARgamma signaling causes cerebral vascular dysfunction hypertrophy and remodeling Hypertension 51 2008 867 871 (Pubitemid 351654697)
6. G. Bomboi, L. Castello, F. Cosentino, F. Giubilei, F. Orzi, and M. Volpe Alzheimer's disease and endothelial dysfunction Neurol Sci 31 1 2010 1 8
7. G. Brosky, and J. Logothetopoulos Streptozotocin diabetes in the mouse and guinea pig Diabetes 18 9 1969 606 611
8. J. Camarasa, T. Rodrigo, D. Pubill, and E. Escubedo Memantine is a useful drug to prevent the spatial and non-spatial memory deficits induced by methamphetamine in rats Pharmacol Res 62 5 2010 450 456
9. R.K. Chaturvedi, P. Adhihetty, S. Shukla, T. Hennessy, N. Calingasan, and L. Yang Impaired PGC-1alpha function in muscle in Huntington's disease Hum Mol Genet 18 2009 3048 3065
10. K. Chopra, V. Tiwari, V. Arora, and A. Kuhad Sesamol suppresses neuro-inflammatory cascade in experimental model of diabetic neuropathy J Pain 11 10 2010 950 957
11. M.J. Cipolla, N. Bishop, R.S. Vinke, and J.A. Godfrey PPAR{gamma} activation prevents hypertensive remodeling of cerebral arteries and improves vascular function in female rats Stroke 41 2010 1266 1270
12. J.C. de la Torre Alzheimer's disease prevalence can be lowered with non-invasive testing J Alzheimers Dis 14 3 2008 353 359 (Pubitemid 352040048)
13. S.Z. Duan, M.G. Usher, and R.M. Mortensen Peroxisome proliferator- activated receptor-gammamediated effects in the vasculature Circ Res 102 2008 283 294 (Pubitemid 351271648)
14. G.L. Ellman, D.K. Courtney, V. Andres, and R.M. Feathstone A new and rapid colorimeteric determination of acetylcholinesterase activity Biochem Pharmacol 7 1961 88 95
15. Z. Fatehi-Hassanabad, and R.A. Tasker Peroxisome proliferator-activated receptors-gamma PPAR-gamma) activation confers functional neuroprotection in global ischemia Neurotox Res 19 3 2011 462 471
16. B. Feng, S. Chen, B. George, Q. Feng, and S. Chakrabarti miR133a regulates cardiomyocyte hypertrophy in diabetes Diabetes Metab Res Rev 26 1 2010 40 49
17. T. Glatz, I. Stock, M. Nguyen-Ngoc, P. Gohlke, T. Herdegen, and J. Culman Peroxisome-proliferator-activated receptors gamma and peroxisome-proliferator- activated receptors beta/delta and the regulation of interleukin 1 receptors antagonist expression by pioglitazone in ischemic brain J Hypertens 28 2010 1488 1497
18. B. Halvorsen, E. Heggen, T. Ueland, C. Smith, W.J. Sandberg, and J.K. Damås Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptors antagonist in individuals with metabolic syndrome Eur J Endocrinol 162 2010 267 273
19. H. Hanyu, and T. Sato Alzheimer's disease Nippon Rinsho 68 2010 330 334
20. M.T. Heneka, and G.E. Landreth PPARs in the brain Biochim Biophys Acta 1771 2007 1031 1045 (Pubitemid 47208548)
21. K. Huynh, J.R. McMullen, T.L. Julius, J.W. Tan, J.E. Love, and N. Cemerlang Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy Diabetes 59 6 2010 1512 1520
22. E. Isingrini, T. Desmidt, C. Belzung, and V. Camus Endothelial dysfunction: a potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease? Curr Opin Investig Drugs 10 1 2009 46 55
23. S.M. Jackson, F. Parhami, X.P. Xi, J.A. Berliner, W.A. Hsueh, and R.E. Law Peroxisome proliferator- activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction Arterioscler Thromb Vasc Biol 19 1999 2094 2104 (Pubitemid 29422240)
24. V. Jain, A.S. Jaggi, and N. Singh Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in rats Pharmacol Res 59 2009 385 392
25. D. Javeshghani, E.L. Schiffrin, M.R. Sairam, and R.M. Touyz Potentiation of vascular oxidative stress and nitric oxide-mediated endothelial dysfunction by high-fat diet in a mouse model of estrogen deficiency and hyperandrogenemia J Am Soc Hypertens 3 5 2009 295 305
26. C. Jing, and A.T. Ting Seed B PPAR gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
27. R.K. Kaundal, and S.S. Sharma Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents Drug News Perspect 23 4 2010 241 256
28. B. Kaur, N. Singh, and A.S. Jaggi Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia Fundam Clin Pharmacol 23 2009 557 566
29. A. Kearney-Schwartz, P. Rossignol, S. Bracard, J. Felblinger, R. Fay, and J.M. Boivin Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints Stroke 40 4 2009 1229 1236
30. M. Kiaei Peroxisome proliferator-activated receptors-gamma in amyotrophic lateral sclerosis and Huntington's disease PPAR Res 2008 2008 418765
31. J.M. Kleinhenz, D.J. Kleinhenz, S. You, J.D. Ritzenthaler, J.M. Hansen, and D.R. Archer Disruption of endothelial peroxisome proliferator-activated receptors-gamma reduces vascular nitric oxide production Am J Physiol Heart Circ Physiol 297 2009 H1647 H1654
32. R.U. Koladiya, A.S. Jaggi, N. Singh, and B.K. Sharma Ameliorative role of atorvastatin and pitavastatin in L-methionine induced vascular dementia in rats BMC Pharmacol 8 2008 14
33. R.U. Koladiya, A.S. Jaggi, N. Singh, and B. Sharma Beneficial effects of donepezil on vascular endothelial dysfunction-associated dementia induced by L-methionine in rats J Health Sci 55 2 2009 215 225
34. N. Krieger-Hinck, U. Schumacher, A. Muller, and U. Valentiner The effect of the PPAR-gamma agonist rosiglitazone on neuroblastoma SK-N-SH cells in a metastatic xenograft mouse model Oncol Res 18 2010 387 393
35. R. Kumari, L.B. Willing, S.D. Patel, J.K. Krady, W.J. Zavadoski, and E.M. Gibbs The PPAR-gamma agonist darglitazone restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob/ob mouse J Cereb Blood Flow Metab 30 2010 352 360
36. G. Landreth Therapeutic use of agonists of the nuclear receptors PPARgamma in Alzheimer's disease Curr Alzheimer Res 4 2007 159 164 (Pubitemid 46557505)
37. G. Landreth, Q. Jiang, S. Mandrekar, and M. Heneka PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease Neurotherapeutics 5 2008 481 489 (Pubitemid 351952487)
38. J.Y. Leung, E.W. Kwok, G.Y. Liu, and C.C. Pang Attenuated alpha-adrenoceptor-mediated arterial and venous constrictions in rat models of diabetes Eur J Pharmacol 642 1-3 2010 128 133
39. W.L. Li, X. Liang, X. Wang, X.D. Zhang, R. Liu, and W. Zhang Protective effect of the peroxisome proliferator-activated receptors PPAR-gamma ligand rosiglitazone on tert-butyl hydroperoxide-induced QZG cell injury Exp Toxicol Pathol 63 6 2011 527 533
40. H. Liu, M. Yang, G.M. Li, Y. Qiu, J. Zheng, and X. Du The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: a meta-analysis J Neurol Sci 294 2010 74 80
41. O.H. Lowry, N.J. Rosebrough, A.L. Far, and R.J. Randall Protein measurement with folin-phenol reagent J Biol Chem 193 1951 265 275
42. J.A. Luchsinger Type 2 diabetes and related conditions in relation to dementia: an opportunity for prevention? J Alzheimers Dis 20 3 2010 723 736
43. F. Marotta, M. Harada, E.D. Dallah, H. Yadav, U. Solimene, and S. Di Lembo Chui DH protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes J Biol Regul Homeost Agents 24 1 2010 41 49
44. R.G.M. Morris Developments of a water maze producer for studying spatial learning in the rats J Neurosci Methods 11 1984 47 60
45. N. Nicolakakis, T. Aboulkassim, B. Ongali, C. Lecrux, P. Fernandes, and P. Rosa-Neto Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone a peroxisome proliferator-activated receptors gamma agonist J Neurosci 28 2008 9287 9296
46. H. Ohokawa, N. Ohishi, and K. Yagi Assay for lipid peroxided in animal tissues by thiobarbituric acid reaction Anal Biochem 95 1979 351 358 (Pubitemid 9194347)
47. M. Olukman, C.E. Orhan, F.G. Celenk, and S. Ulker Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions J Diabetes Complications 24 6 2010 415 423
48. A. Ozkul, M. Ayhan, C. Yenisey, A. Akyol, E. Guney, and F.A. Ergin The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain Neuro Endocrinol Lett 31 2 2010 261 264
49. M.G. Packard, L.A. Teather, and N.G. Bazan Effect of intra-striated injectins of platelet-activating factor and PAF antagonist BN 52021 on memory Neurol Learn Mem 66 1996 176 182 (Pubitemid 26423877)
50. L. Pari, and S. Srinivasan Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats Biomed Pharmacother 64 7 2010 477 481
51. M. Parle, and N. Singh Reversal of memory deficits by atorvastatin and simvastatin in rats Yakugaku Zasshi 127 2007 1125 1137 (Pubitemid 47035644)
52. V. Pasceri, H.D. Wu, J.T. Willerson, and E.T. Yeh Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptorgamma activators Circulation 101 2000 235 238 (Pubitemid 30054148)
53. A.R. Pathan, B. Viswanad, S.K. Sonkusare, and P. Ramarao Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats Life Sci 79 2006 2209 2216 (Pubitemid 44646475)
54. G.M. Pieper Diabetic induced endothelial dysfunction in rat aorta: role of hydroxyl radicals Cardiovasc Res 34 1997 145 156 (Pubitemid 27261923)
55. J.A. Polikandriotis, L.J. Mazzella, H.L. Rupnow, and C.M. Hart Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms Arterioscler Thromb Vasc Biol 25 2005 1810 1816 (Pubitemid 41243447)
56. N. Rakieten, M.L. Rakieten, and M.V. Nandkarni Studies on the diabetogenic action of streptozotocin NSC-37917 Cancer Chemother Rep 29 1963 91 98
57. V.R. Rao, E. Prescott, N.B. Shelke, R. Trivedi, P. Thomas, and C. Struble Delivery of SAR 1118 to retina via ophthalmic drops and its effectiveness in reduction of retinal leukostasis and vascular leakiness in rat streptozotocin STZ model of diabetic retinopathy DR Invest Ophthalmol Vis Sci 51 10 2010 5198 5204
58. M. Ricote, J.T. Huang, J.S. Welch, and C.K. Glass The peroxisome proloferator receptor gamma as a regulator of monocyte/macrophage function J Leukoc Biol 66 1999 733 739 (Pubitemid 29532032)
59. F.E. Saravia, J. Beauquis, Y. Revsin, F. Homo-Delarche, E.R. de Kloet, and A.F. De Incola Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment Cell Mol Neurobiol 26 4-6 2006 943 957
60. D.A. Sarruf, F. Yu, H.T. Nguyen, D.L. Williams, R.L. Printz, and K.D. Niswender Expression of peroxisome proliferator-activated receptors-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis Endocrinology 150 2009 707 712
61. K.V. Sastry, R.P. Moudgal, J. Mohan, J.S. Tyagi, and G.S. Rao Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy Anal Biochem 306 1 2002 79 82 (Pubitemid 34722019)
62. A. Schafer, C. Vogt, D. Fraccarollo, J. Widder, U. Flierl, and S.K. Hildemann Eplerenone improves vascular function and reduces platelet activation in diabetic rats J Physiol Pharmacol 61 1 2010 45 52
63. N. Schintu, L. Frau, M. Ibba, P. Caboni, A. Garau, and E. Carboni PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease Eur J Neurosci 29 2009 954 963
64. A. Sekita, and Y. Kiyohara Lifestyle-related diseases as risk factors for dementia Brain Nerve 62 7 2010 709 717
65. B. Sharma, and N. Singh Pitavastatin and 4′-Hydroxy-3′- methoxyacetophenone HMAP reduce cognitive dysfunction in vascular dementia during experimental diabetes Curr Neurovasc Res 7 2010 180 191
66. B. Sharma, and N. Singh Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats Psychopharmacology (Berl) 215 4 2011 677 687
67. B. Sharma, N. Singh, and A.S. Jaggi Exploration of HIV protease inhibitor indinavir as a memory restorative agent in experimental induced dementia Pharmacol Biochem Behav 89 2008 535 545
68. B. Sharma, N. Singh, and M. Singh Modulation of celecoxib and streptozotocin-induced experimental dementia of Alzheimer's disease type by pitavastatin and donepezil J Psychopharmacol 22 2008 162 171 (Pubitemid 351322854)
69. J. Sokolovska, S. Isajevs, O. Sugoka, J. Sharipova, L. Lauberte, and D. Svirina Influence of metformin on GLUT1 gene and protein expression in rat streptozotocin diabetes mellitus model Arch Physiol Biochem 116 3 2010 137 145
70. K. Tsuchiya, I. Akaza, T. Yoshimoto, and Y. Hirata Pioglitazone improves endothelial function with increased adiponectin and high-density lipoprotein cholesterol levels in type 2 diabetes Endocr J 56 5 2009 691 698
71. H. Umegaki Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration? Age Ageing 39 2010 8 10
72. E. Verrier, L. Wang, C. Wadham, N. Albanese, C. Hahn, and J.R. Gamble PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase Circ Res 94 2004 1515 1522 (Pubitemid 38780325)
73. A. Viswanathan, W.A. Rocca, and C. Tzourio Vascular risk factors and dementia how to move forward Neurology 72 2009 368 374
74. G. Voss, and K. Sachsse Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylthiocholine / DTNB Procedure Toxicol Appl Pharmacol 16 1970 764 772
75. H.D. Wang, P.J. Pagano, and Y. Du Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide Circ Res 82 1998 810 818 (Pubitemid 28185849)
76. Q. Wang, J. Yan, X. Chen, J. Li, Y. Yang, and J. Weng Statins: multiple neuroprotective mechanisms in neurodegenerative diseases Exp Neurol 230 1 2011 27 34
77. A.R. Weseler, and A. Bast Oxidative stress and vascular function: implications for pharmacologic treatments Curr Hypertens Rep 12 3 2010 154 161
78. O.L. Woodman, and W. Malakul 3′4′-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta Life Sci 85 1-2 2009 54 59
79. L. Xu, B. Li, M. Cheng, J. Pan, C. Zhang, and H. Gao Oral administration of grape seed proanthocyanidin extracts downregulate RAGE dependant nuclear factor - kappa BP65 expression in the hippocampus of streptozotocin induced diabetic rats Exp Clin Endocrinol Diabetes 116 4 2008 215 224 (Pubitemid 351600583)
80. E. Yohannes, J. Chang, M.T. Tar, K.P. Davies, and M.R. Chance Molecular targets for diabetes mellitus-associated erectile dysfunction Mol Cell Proteomics 9 3 2010 565 578
81. J. Yu, Z. Zhang, Z. Li, X. Feng, L. He, and S. Liu Peroxisome proliferator-activated receptors-gamma PPARgamma agonist improves coronary artery endothelial function in diabetic patients with coronary artery disease J Int Med Res 38 2010 86 94
82. Q. Zhang, W. Hu, B. Meng, and T. Tang PPARgamma agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats Neurol Res 2010 PMID: 20350367 [Epub ahead of print]
83. T. Zhang, B.S. Pan, G.C. Sun, X. Sun, and F.Y. Sun Diabetes synergistically exacerbates poststroke dementia and tau abnormality in brain Neurochem Int 56 8 2010 955 961
84. X. Zhao, R. Strong, J. Zhang, G. Sun, J.Z. Tsien, and Z. Cui Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia J Neurosci 29 2009 6186 6195
85. J. Zhou, L. Wang, S. Ling, and X. Zhang Expression changes of growth-associated protein-43 GAP-43 and mitogen-activated protein kinase phosphatase-1 MKP-1 and in hippocampus of streptozotocin-induced diabetic cognitive impairment rats Exp Neurol 206 2 2007 201 208 (Pubitemid 47094764)